- $292.84m
- $349.14m
- $318.99m
- 53
- 57
- 48
- 52
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 173 | 210 | 258 | 309 | 319 |
Cost of Revenue | |||||
Gross Profit | 117 | 153 | 191 | 236 | 244 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 289 | 283 | 346 | 398 | 374 |
Operating Profit | -115 | -73.1 | -88.5 | -88.9 | -54.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -125 | -84.2 | -103 | -104 | -74.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -126 | -84.6 | -102 | -106 | -75.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -126 | -84.6 | -102 | -106 | -75.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -126 | -84.6 | -102 | -106 | -75.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -4.57 | -2.87 | -3.19 | -3.1 | -2.05 |